Jang Se-Won, Jo Ha-Neul, Han Yoon-Young, Lee Jae-Sun, Kim Bo-Mi, Kim Ji-Min, Lee Yong-Wook, Park Chan-Sung, Lee Dae-Young, Kim Kwan-Woo, Lee Young-Seob
Herbal Hormone Research Institute, Naturalendo Tech Co. Ltd., Gyeonggi-Do, 13486 Republic of Korea.
Industrial Crop Utilization Division, Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, 27709 Republic of Korea.
Food Sci Biotechnol. 2024 Feb 26;33(11):2611-2621. doi: 10.1007/s10068-024-01521-3. eCollection 2024 Aug.
Turczaninow (PU), a traditional Korean medicinal herb, exhibits osteogenic and anti-inflammatory effects. This research explored the effect of PU extracts on hyperimmune responses within the respiratory tract using lipopolysaccharide-stimulated RAW 264.7 cells and an ovalbumin-induced hyper-responsiveness model. The inflammatory cytokines, protein expression linked to airway inflammation, antioxidant enzyme activity, histopathological observation, and expectorant activity were measured. The results revealed that PU treatment led to a concentration-dependent reduction in Th2 cytokines and the expression of nuclear factor (NF)-κB, phosphatase-tensin homolog, mitogen-activated protein kinase (MAPK), and inducible nitric oxide synthase (iNOS). Simultaneously, antioxidant enzyme activity increased. Furthermore, PU exhibited substantial enhancements in lung tissue condition and expectorant activity relative to the allergic rhinitis-induced group. These findings indicate the potential of PU to mitigate airway inflammation and excessive mucus production by suppressing NF-κB, MAPK, and iNOS pathways. Consequently, PU emerges as a promising anti-inflammatory agent for respiratory tract applications.
The online version contains supplementary material available at 10.1007/s10068-024-01521-3.
图尔察尼诺夫(PU)是一种传统的韩国草药,具有成骨和抗炎作用。本研究使用脂多糖刺激的RAW 264.7细胞和卵清蛋白诱导的高反应性模型,探讨了PU提取物对呼吸道内超敏反应的影响。检测了炎性细胞因子、与气道炎症相关的蛋白表达、抗氧化酶活性、组织病理学观察和祛痰活性。结果显示,PU处理导致Th2细胞因子以及核因子(NF)-κB、磷酸酶张力蛋白同源物、丝裂原活化蛋白激酶(MAPK)和诱导型一氧化氮合酶(iNOS)的表达呈浓度依赖性降低。同时,抗氧化酶活性增加。此外,相对于变应性鼻炎诱导组,PU在肺组织状况和祛痰活性方面有显著增强。这些发现表明,PU有潜力通过抑制NF-κB、MAPK和iNOS途径减轻气道炎症和过多的黏液分泌。因此,PU有望成为一种用于呼吸道的抗炎剂。
在线版本包含可在10.1007/s10068-024-01521-3获取的补充材料。